Last reviewed · How we verify
glicazide
At a glance
| Generic name | glicazide |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES (PHASE4)
- Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes (PHASE4)
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |